{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:14:17Z","timestamp":1788347657909,"version":"build-2803163510"},"posted":{"date-parts":[[2026,7,1]]},"group-title":"Bioengineering","reference-count":56,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"award":["R01NS111292"],"award-info":[{"award-number":["R01NS111292"]}],"id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01HD099543"],"award-info":[{"award-number":["R01HD099543"]}],"id":[{"id":"https:\/\/ror.org\/04byxyr05","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/05d56bw89","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Leptomeningeal disease (LD) refers to the metastasis of cells to the leptomeningeal membranes in the central nervous system (CNS), and it is a deadly complication of several different types of cancer, including breast cancer (BC) and pediatric medulloblastoma (MB). Angiopep-2 (Ang2) and transactivating transcriptional activator (TAT) peptides have been reported to transport therapeutic cargos into the CNS. Here, compared the LD-targeting capability of Ang2 vs TAT by intrathecal (intracisternal magna, ICM) vs intravenous (IV) routes of administration. We first generated two xenograft models of LD by directly infusing breast cancer cells (MDA-MB231) or medulloblastoma cells (HDMB03) via the ICM route, characterizing models for survival, tumor growth patterns, and presence of hydrocephalus. Second, we administered fluorescently labeled Ang2 or TAT peptides either IV or ICM into tumor bearing mice to examine ligand localization. We discovered that the median survival of both models was negatively related to the number of the cells infused. While HDMB03 cells tended to metastasize preferentially to the brain region, MDA-MB231 cells tended to metastasize preferentially to the spinal cord. Compared to the healthy control, MB-LD yielded a 7.3-fold increase and BC-LD a 26.5-fold increase in ventricular volume. Furthermore, targeting achieved by TAT was significantly higher than targeting achieved by Ang2 in thoracic spine for the MB-LD model. For BC-LD, TAT targeting was superiot to Ang2 in the olfactory bulbs, brain stem, thoracic spine, and lumbar spine regions. Significantly, these data provide evidence that ICM will be a preferable route of administration over IV for maximally targeting LD.<\/jats:p>","DOI":"10.64898\/2026.06.29.735336","type":"posted-content","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:45:06Z","timestamp":1782906306000},"source":"Crossref","is-referenced-by-count":0,"title":["Ang2 and TAT targeting of leptomeningeal disease by the intravenous and intrathecal routes: a comparative analysis"],"prefix":"10.64898","author":[{"given":"Chung-Fan","family":"Kuo","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School, Worcester MA, USA"},{"name":"Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobi","family":"Babayemi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School, Worcester MA, USA"},{"name":"Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester MA, USA"},{"name":"Department of Bioengineering, Rice University, Houston TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kha Uyen","family":"Dam","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School, Worcester MA, USA"},{"name":"Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiology, UMass Chan Medical School, Worcester MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School, Worcester MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael W.","family":"Sirianni","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, UMass Chan Medical School, Worcester MA, USA"},{"name":"Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester MA, USA"},{"name":"Department of Bioengineering, Rice University, Houston TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026090203250660000_2026.06.29.735336v2.1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou089"},{"key":"2026090203250660000_2026.06.29.735336v2.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100898"},{"issue":"2","key":"2026090203250660000_2026.06.29.735336v2.3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12254-021-00693-6","article-title":"Leptomeningeal metastases from solid tumours","volume":"14","year":"2021","journal-title":"memo-Magazine of European Medical Oncology"},{"issue":"4","key":"2026090203250660000_2026.06.29.735336v2.4","first-page":"362","article-title":"Leptomeningeal disease and the evolving role of molecular targeted therapy and immunotherapy","volume":"17","year":"2017","journal-title":"Ochsner Journal"},{"issue":"3","key":"2026090203250660000_2026.06.29.735336v2.5","doi-asserted-by":"crossref","first-page":"e24171","DOI":"10.1002\/pep2.24171","article-title":"Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates","volume":"112","year":"2020","journal-title":"Peptide Science"},{"issue":"1","key":"2026090203250660000_2026.06.29.735336v2.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2022.2154409","article-title":"Recent advances in drug delivery systems for targeting brain tumors","volume":"30","year":"2023","journal-title":"Drug delivery"},{"issue":"12","key":"2026090203250660000_2026.06.29.735336v2.7","doi-asserted-by":"crossref","first-page":"2302902","DOI":"10.1002\/adhm.202302902","article-title":"Insights into targeted and stimulus-responsive nanocarriers for brain cancer treatment","volume":"13","year":"2024","journal-title":"Advanced Healthcare Materials"},{"key":"2026090203250660000_2026.06.29.735336v2.8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3258"},{"key":"2026090203250660000_2026.06.29.735336v2.9","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90263-2"},{"key":"2026090203250660000_2026.06.29.735336v2.10","doi-asserted-by":"publisher","DOI":"10.3762\/bjnano.11.10"},{"issue":"7","key":"2026090203250660000_2026.06.29.735336v2.11","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1021\/acsbiomaterials.3c00263","article-title":"Angiopep-2 grafted PAMAM dendrimers for the targeted delivery of temozolomide: in vitro and in vivo effects of PEGylation in the management of glioblastoma multiforme","volume":"9","year":"2023","journal-title":"ACS biomaterials science & engineering"},{"issue":"10","key":"2026090203250660000_2026.06.29.735336v2.12","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1021\/acsami.3c14709","article-title":"Angiopep-2-functionalized lipid cubosomes for blood\u2013brain barrier crossing and glioblastoma treatment","volume":"16","year":"2024","journal-title":"ACS applied materials & interfaces"},{"key":"2026090203250660000_2026.06.29.735336v2.13","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.260"},{"key":"2026090203250660000_2026.06.29.735336v2.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.04.031"},{"issue":"1","key":"2026090203250660000_2026.06.29.735336v2.15","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1038\/srep08029","article-title":"Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer","volume":"5","year":"2015","journal-title":"Scientific reports"},{"issue":"6","key":"2026090203250660000_2026.06.29.735336v2.16","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1021\/acs.molpharmaceut.6b00004","article-title":"Cell-penetrating peptide-modified gold nanoparticles for the delivery of doxorubicin to brain metastatic breast cancer","volume":"13","year":"2016","journal-title":"Molecular pharmaceutics"},{"key":"2026090203250660000_2026.06.29.735336v2.17","first-page":"77","article-title":"Intrathecal drug delivery in the era of nanomedicine","volume":"165","year":"2020","journal-title":"Advanced drug delivery reviews"},{"key":"2026090203250660000_2026.06.29.735336v2.18","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200103040-00001"},{"key":"2026090203250660000_2026.06.29.735336v2.19","unstructured":"E. Bustamante et al., \u201cBrain Metastasis in Triple-Negative Breast Cancer,\u201d The breast journal, vol. 2024, no. 1, p. 8816102, 2024."},{"issue":"11","key":"2026090203250660000_2026.06.29.735336v2.20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2176\/nmc.ra.2016-0016","article-title":"Molecular classification of medulloblastoma","volume":"56","year":"2016","journal-title":"Neurologia medico-chirurgica"},{"issue":"5","key":"2026090203250660000_2026.06.29.735336v2.21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/mrm.20047","article-title":"Direct CSF injection of MnCl2 for dynamic manganese-enhanced MRI","volume":"51","year":"2004","journal-title":"Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine"},{"issue":"10","key":"2026090203250660000_2026.06.29.735336v2.22","doi-asserted-by":"crossref","first-page":"e0292681","DOI":"10.1371\/journal.pone.0292681","article-title":"TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor- mediated endocytosis or peptide-inflicted barrier disruption","volume":"18","year":"2023","journal-title":"PLoS One"},{"key":"2026090203250660000_2026.06.29.735336v2.23","unstructured":"A. I. Baba and C. C\u00e2toi , \u201cTumor cell morphology,\u201d in Comparative oncology: The Publishing House of the Romanian Academy, 2007."},{"key":"2026090203250660000_2026.06.29.735336v2.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2949-7"},{"key":"2026090203250660000_2026.06.29.735336v2.25","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.1999.0119"},{"key":"2026090203250660000_2026.06.29.735336v2.26","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3987-12.2012"},{"key":"2026090203250660000_2026.06.29.735336v2.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00700-y"},{"key":"2026090203250660000_2026.06.29.735336v2.28","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30911"},{"issue":"11","key":"2026090203250660000_2026.06.29.735336v2.29","first-page":"4655","article-title":"Recent trends in epidemiology of brain metastases: an overview","volume":"32","year":"2012","journal-title":"Anticancer research"},{"key":"2026090203250660000_2026.06.29.735336v2.30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.wneu.2020.04.087","article-title":"Severe radiation necrosis refractory to surgical resection in patients with melanoma and brain metastases managed with ipilimumab\/nivolumab and brain-directed stereotactic radiation therapy","volume":"139","year":"2020","journal-title":"World Neurosurgery"},{"key":"2026090203250660000_2026.06.29.735336v2.31","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou099"},{"key":"2026090203250660000_2026.06.29.735336v2.32","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-8093-6"},{"key":"2026090203250660000_2026.06.29.735336v2.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.08.010"},{"key":"2026090203250660000_2026.06.29.735336v2.34","doi-asserted-by":"crossref","unstructured":"N. M. Almansour , \u201cTriple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence,\u201d Frontiers in molecular biosciences, vol. 9, p. 836417, 2022.","DOI":"10.3389\/fmolb.2022.836417"},{"key":"2026090203250660000_2026.06.29.735336v2.35","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou327"},{"key":"2026090203250660000_2026.06.29.735336v2.36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.4324"},{"key":"2026090203250660000_2026.06.29.735336v2.37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01148"},{"key":"2026090203250660000_2026.06.29.735336v2.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.017"},{"key":"2026090203250660000_2026.06.29.735336v2.39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1764"},{"issue":"2","key":"2026090203250660000_2026.06.29.735336v2.40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/neuonc\/noac180","article-title":"Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis","volume":"25","year":"2023","journal-title":"Neuro-oncology"},{"issue":"4","key":"2026090203250660000_2026.06.29.735336v2.41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41591-022-02170-x","article-title":"Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results","volume":"29","year":"2023","journal-title":"Nature medicine"},{"key":"2026090203250660000_2026.06.29.735336v2.42","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz201"},{"issue":"1","key":"2026090203250660000_2026.06.29.735336v2.43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14791\/btrt.2022.0037","article-title":"Advances in brain metastasis models","volume":"11","year":"2023","journal-title":"Brain Tumor Research and Treatment"},{"issue":"5","key":"2026090203250660000_2026.06.29.735336v2.44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10585-013-9566-9","article-title":"In vivo animal models for studying brain metastasis: value and limitations","volume":"30","year":"2013","journal-title":"Clinical & experimental metastasis"},{"key":"2026090203250660000_2026.06.29.735336v2.45","doi-asserted-by":"crossref","unstructured":"C. Zhang , F. J. Lowery , and D. Yu , \u201cIntracarotid cancer cell injection to produce mouse models of brain metastasis,\u201d Journal of visualized experiments: JoVE, no. 120, p. 55085, 2017.","DOI":"10.3791\/55085-v"},{"key":"2026090203250660000_2026.06.29.735336v2.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02769-5"},{"key":"2026090203250660000_2026.06.29.735336v2.47","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006237917632"},{"issue":"3","key":"2026090203250660000_2026.06.29.735336v2.48","doi-asserted-by":"crossref","first-page":"e150881","DOI":"10.1172\/jci.insight.150881","article-title":"Magnetic resonance imaging of cerebrospinal fluid outflow after low-rate lateral ventricle infusion in mice","volume":"7","year":"2022","journal-title":"JCI insight"},{"key":"2026090203250660000_2026.06.29.735336v2.49","doi-asserted-by":"crossref","unstructured":"D. D. Gonda , T. E. Kim , P. C. Warnke , E. M. Kasper , B. S. Carter , and C. C. Chen , \u201cVentriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis,\u201d Surgical neurology international, vol. 3, p. 97, 2012.","DOI":"10.4103\/2152-7806.100185"},{"issue":"2","key":"2026090203250660000_2026.06.29.735336v2.50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11060-010-0512-2","article-title":"Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis","volume":"104","year":"2011","journal-title":"Journal of neuro-oncology"},{"issue":"03","key":"2026090203250660000_2026.06.29.735336v2.51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0043-1774308","article-title":"Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in patients with obstructive hydrocephalus: an updated systematic review and meta- analysis","volume":"18","year":"2023","journal-title":"Asian Journal of Neurosurgery"},{"key":"2026090203250660000_2026.06.29.735336v2.52","doi-asserted-by":"crossref","unstructured":"D. D. Limbrick Jr and J. R. Leonard , Cerebrospinal fluid disorders: lifelong implications. Springer, 2018.","DOI":"10.1007\/978-3-319-97928-1"},{"issue":"2","key":"2026090203250660000_2026.06.29.735336v2.53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11060-017-2452-6","article-title":"Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe","volume":"133","year":"2017","journal-title":"Journal of neuro- oncology"},{"key":"2026090203250660000_2026.06.29.735336v2.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.12.016"},{"key":"2026090203250660000_2026.06.29.735336v2.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.07.030"},{"issue":"10","key":"2026090203250660000_2026.06.29.735336v2.56","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/ph5101092","article-title":"Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors","volume":"5","year":"2012","journal-title":"Pharmaceuticals"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.29.735336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:25:16Z","timestamp":1788344716000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.29.735336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":56,"URL":"https:\/\/doi.org\/10.64898\/2026.06.29.735336","relation":{},"subject":[],"published":{"date-parts":[[2026,7,1]]},"subtype":"preprint"}}